Related Experiment Videos
Targets for vascular protection after acute ischemic stroke
Susan C Fagan1, David C Hess, Elizabeth J Hohnadel
1Program in Clinical and Experimental Therapeutics, College of Pharmacy, University of Georgia, Athens, Ga 30912-2450, USA. sfagan@mail.mcg.edu
Stroke
|July 31, 2004
Summary
Vascular damage in ischemic stroke worsens patient outcomes. This review identifies key pathophysiologic processes and therapeutic targets for vascular protection strategies during acute, subacute, and chronic phases.
Area of Science:
- Neuroscience
- Vascular Biology
- Pathophysiology
Background:
- Cerebral ischemia causes vascular damage, leading to edema, hemorrhage, and poor outcomes in stroke patients.
- Developing effective therapeutic interventions for vascular protection is crucial for improving stroke patient prognosis.
- Understanding the mechanisms of vascular injury post-ischemia is key to devising protective strategies.
Purpose of the Study:
- To identify the pathophysiologic processes involved in vascular damage following cerebral ischemia.
- To explore potential strategies for providing vascular protection in ischemic stroke patients based on identified mechanisms.
Main Methods:
- Literature review of pathophysiologic processes in cerebral ischemia.
- Analysis of temporal progression of vascular injury (acute, subacute, chronic).
- Identification of key mediators and targets for therapeutic intervention at different stages.
Main Results:
- Vascular injury progresses through acute (hours), subacute (hours to days), and chronic (days to months) phases.
- Superoxide is a primary mediator in the acute phase, followed by inflammatory mediators and proteases in the subacute phase.
- Proapoptotic gene products are implicated in the chronic phase of vascular injury.
Conclusions:
- Specific pathophysiologic and protective processes affecting the vasculature can be targeted for intervention.
- Pharmacological agents targeting these processes should be evaluated in clinical trials for acute ischemic stroke.
- Developing stage-specific vascular protection strategies is essential for improving outcomes in ischemic stroke.